Contact Details
Matt Riley - Head of Investor Relations & Corporate Communications
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022
By:
TheNewswire.com
October 21, 2022 at 11:00 AM EDT
Contact DetailsMatt Riley - Head of Investor Relations & Corporate Communications Company Websitehttps://agiletherapeutics.com/ More NewsView More
Breakout Alert: Disney Stock Hits Multi-Year High
July 01, 2025
Via MarketBeat
Tickers
DIS
Forget IBM: Accenture’s AI Momentum Is Your Next Buy
July 01, 2025
2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign
July 01, 2025
Via MarketBeat
Via MarketBeat
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|